317 related articles for article (PubMed ID: 36731451)
1. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
3. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
4. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine for skin cancer prevention in solid organ transplant recipients.
Jirakulaporn T; Endrizzi B; Lindgren B; Mathew J; Lee PK; Dudek AZ
Clin Transplant; 2011; 25(4):541-8. PubMed ID: 21050273
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
7. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
8. Skin Cancers in Medicare Beneficiaries With Actinic Keratoses.
Mohr C; Li Y; Navsaria LJ; Hinkston CL; Shete SS; Margolis DJ; Wehner MR
JAMA Dermatol; 2023 Dec; 159(12):1368-1372. PubMed ID: 37938822
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis.
Liew YCC; De Souza NNA; Sultana RG; Oh CC
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):251-259. PubMed ID: 31394005
[TBL] [Abstract][Full Text] [Related]
10. Metal arc welding and the risk of skin cancer.
Heltoft KN; Slagor RM; Agner T; Bonde JP
Int Arch Occup Environ Health; 2017 Nov; 90(8):873-881. PubMed ID: 28766013
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
12. Actinic keratosis-related signs predictive of squamous cell carcinoma in renal transplant recipients: a nested case-control study.
Jiyad Z; O'Rourke P; Soyer HP; Green AC
Br J Dermatol; 2017 Apr; 176(4):965-970. PubMed ID: 27584866
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
Tee LY; Sultana R; Tam SYC; Oh CC
J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
[No Abstract] [Full Text] [Related]
14. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
[TBL] [Abstract][Full Text] [Related]
15. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
16. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
17. Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients.
Oliveira WRP; Tirico MCCP; Souza AAV; Codarin FR; Silva LLC; Festa Neto C
Int J Dermatol; 2019 Apr; 58(4):440-448. PubMed ID: 30565651
[TBL] [Abstract][Full Text] [Related]
18. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
[TBL] [Abstract][Full Text] [Related]
19. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]